Las inyecciones de moda para adelgazar tambin podran reducir el riesgo de demencia La semaglutida ya ha demostrado una amplia gama de beneficios asociados al control de la glucosa y la prdida de peso La semaglutid a , el principio activo de las populares inyecciones para adelgazar y controlar la diabetes, Ozempic y Wegovy, est demostrando cada vez ms evidencia en otras enfermedades, Investigadores de la Facultad de Medicina Case Western Reserve han descubierto que el popular frmaco para la prdida de peso puede reducir el riesgo de demencia en personas con diabetes tipo 2
It is better to seek professional guidance than to risk potential health issues
In addition to blunted monoaminergic neurotransmission, it was also shown that deficiency in neurotrophic factor effects, disturbances in neurogenesis and synaptogenesis, chronic neuroinflammatory processes, and dysregulation of the hypothalamicpituitaryadrenal (HPA) axis can largely contribute to the manifestation of depressive symptoms in patients [3,4,5]
Author contributions XW and YC: contributed to the manuscript writing and analyses
Once someone goes off a GLP-1, most peoples weight goes back to its baseline after three years
